We are live on ! Find out more
RLYB icon

Rallybio

54 hedge funds and large institutions have $76.1M invested in Rallybio in 2023 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 19 increasing their positions, 10 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

90% more repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 10

0.22% more ownership

Funds ownership: 10.32%10.54% (+0.22%)

7% less funds holding

Funds holding: 5854 (-4)

25% less funds holding in top 10

Funds holding in top 10: 43 (-1)

25% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 12

28% less capital invested

Capital invested by funds: $105M → $76.1M (-$29M)

Holders
54
Holders Change
-4
Holders Change %
-6.9%
% of All Funds
0.79%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.04%
New
9
Increased
19
Reduced
10
Closed
12
Calls
Puts
Net Calls
Net Calls Change

RLYB Hedge Fund Activity: Q4 2023 in Review

54 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Rallybio (RLYB) for Q4 2023, worth a combined $76.1M — down 28% from $105M a quarter earlier.

Sellers outnumbered buyers: 12 funds closed out of RLYB and 9 opened new positions — a net loss of 3 holders — while 10 trimmed existing stakes and 19 added.

The largest buyer was Aberdeen Group, opening a new position worth an estimated $5.28M. The largest seller was Fidelity Investments, cutting an estimated $2.17M.

  • 54 institutional investors held Rallybio (RLYB) as of Q4 2023, down from 58 in Q3 2023.
  • Funds reported $76.1M of Rallybio stock for Q4 2023, down 28% quarter-over-quarter.
  • 9 funds opened new Rallybio positions in Q4 2023 and 12 closed out, a net change of -3 holders.
  • The largest Rallybio buyer in Q4 2023 was Aberdeen Group, an estimated $5.28M added.
  • The largest Rallybio seller in Q4 2023 was Fidelity Investments, an estimated $2.17M sold.

Based on aggregated 13F filings for Q4 2023.